Literature DB >> 350677

C-peptide secretion during the remission phase of juvenile diabetes.

E Heinze, W Beischer, L Keller, G Winkler, W M Teller, E F Pfeiffer.   

Abstract

C-peptide secretion was studied in eight juvenile diabetics during the remission phase of the disease. The release of C-peptide was measured after a (1) normal intravenous glucose tolerance test, (2) a double glucose tolerance test, (3) an arginine infusion, and (4) after an intravenous glucose tolerance test followed by an arginine infusion. Under all conditions the intravenous glucose load had only a minimal effect on the secretion of C-peptide, while arginine alone or after the intravenous glucose tolerance test stimulated the release of the peptide in all patients. Pretreatment with glucose did not augment the effect of arginine on C-peptide release. The results indicate that during the remission phase of juvenile-onset diabetes the endocrine pancreas does not recognize glucose as and appropriate signal for C-peptide release and cannot transform the amplifying effect of glucose into a higher hormonal secretion rate.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 350677     DOI: 10.2337/diab.27.6.670

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  6 in total

1.  Insulinopenia in impaired glucose tolerance preservation of insulin response to I.V. arginine and tolbutamide.

Authors:  J P Monson; L J Borthwick; G S Spathis; S R Bloom
Journal:  Acta Diabetol Lat       Date:  1980 Jan-Mar

2.  Remission from insulin dependence induced by continuous subcutaneous insulin infusion (CSII) in type I, newly diagnosed diabetics: role of some hormonal and immunologic factors.

Authors:  G M Nardelli; E Guastamacchia; S Di Paolo; V Lattanzi; A Ciampolillo; P Montedoro; R Giorgino
Journal:  Acta Diabetol Lat       Date:  1988 Oct-Dec

3.  The effect of glucose, tolbutamide, and arginine on C-peptide release during remission in type I diabetes mellitus.

Authors:  U Vetter; E Heinze; A Thon; W Beischer; W Teller
Journal:  Eur J Pediatr       Date:  1983-09       Impact factor: 3.183

4.  Sustained initial remission induced by intensive insulin treatment in type I diabetes. Possible role of the genetic background.

Authors:  P Vague; B Vialettes; V Lassmann; J P Moulin; P Mercier
Journal:  Acta Diabetol Lat       Date:  1985 Oct-Dec

5.  Beta-cell function recovery is not the only factor responsible for remission in type I diabetics: evaluation of C-peptide secretion in diabetic children after first metabolic recompensation and at partial remission phase.

Authors:  E Schober; G Schernthaner; H Frisch; M Fink
Journal:  J Endocrinol Invest       Date:  1984-10       Impact factor: 4.256

6.  Characterisation of the endocrine pancreas in type 1 diabetes: islet size is maintained but islet number is markedly reduced.

Authors:  Peter Seiron; Anna Wiberg; Enida Kuric; Lars Krogvold; Frode L Jahnsen; Knut Dahl-Jørgensen; Oskar Skog; Olle Korsgren
Journal:  J Pathol Clin Res       Date:  2019-09-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.